| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/25/2006 | CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds |
| 04/20/2006 | WO2006042104A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 04/20/2006 | WO2006041961A1 Arylthioindole tubulin polymerization inhibitors and methods of treating or preventing cancer using same |
| 04/20/2006 | WO2006041197A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ |
| 04/20/2006 | WO2006041135A1 STAT3 PHOSPHORYLATION INHIBITOR AND Notch1 EXPRESSION INHIBITOR |
| 04/20/2006 | WO2006041119A1 Hydrazide derivatives |
| 04/20/2006 | WO2006041037A1 Novel pyridine derivative |
| 04/20/2006 | WO2006040940A1 Intestinal polyp inhibitor |
| 04/20/2006 | WO2006040914A1 Process for producing concentrate of unsaturated fatty acid |
| 04/20/2006 | WO2006040646A1 Benzimidazole or indole amides as inhibitors of pin1 |
| 04/20/2006 | WO2006040579A1 Bioactive polymers |
| 04/20/2006 | WO2006040569A1 Thiophene amide compounds for use in the treatment or prophylaxis of cancers |
| 04/20/2006 | WO2006040568A1 Quinoxalines as b raf inhibitors |
| 04/20/2006 | WO2006040526A1 Quinazoline derivatives for use against cancer |
| 04/20/2006 | WO2006040522A1 Quinoline derivatives |
| 04/20/2006 | WO2006040281A1 Thiazolyl-dihydro indazoles |
| 04/20/2006 | WO2006040279A1 Pi3 kinases |
| 04/20/2006 | WO2006040196A1 4-hydroxy tamoxifen gel formulations |
| 04/20/2006 | WO2006040056A1 Heterocyclic substituted bisarylurea derivatives as kinase inhibitors |
| 04/20/2006 | WO2006040052A1 1,5-naphthyridine azolidinones having cdk1 antiproliferative activity |
| 04/20/2006 | WO2006040050A1 Quinazolinylmethylene thiazolinones as cdk1 inhibitors |
| 04/20/2006 | WO2006040049A1 Novel azaindole thiazolinones as anti-cancer agents |
| 04/20/2006 | WO2006040047A2 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 04/20/2006 | WO2006040039A1 N,n'-dithenylurea derivatives used in the form of kinase inhibitors |
| 04/20/2006 | WO2006040036A1 Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer |
| 04/20/2006 | WO2006039807A1 Methods and therapeutic compositions comprising plant extracts for the treatment of cancer |
| 04/20/2006 | WO2006039806A1 Depression of herg k+ channel function in mammalian cells and applications to the control of cancer cells division |
| 04/20/2006 | WO2006021888A3 Dihydrofolate reductase inhibition by epigallocatechin gallate compounds |
| 04/20/2006 | WO2006021335A3 Peptide mixture from peptides having a molecular weight of from 1000 to 5000 dalton |
| 04/20/2006 | WO2006021002A3 Compounds useful for inhibiting chk1 |
| 04/20/2006 | WO2006014903A3 Compositions and methods of use for adam12 antagonists in treating disease |
| 04/20/2006 | WO2006013420A3 Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (bph) |
| 04/20/2006 | WO2006009755A3 Azaindoles modulating c-kit activity and uses therefor |
| 04/20/2006 | WO2005123115A8 Methods of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants |
| 04/20/2006 | WO2005120588A3 Peptides delivered to cell nuclei |
| 04/20/2006 | WO2005112969A3 Herstatin or intron 8-encoded domain thereof for modulating signaling mediated by igf-1 receptor and erbb receptors |
| 04/20/2006 | WO2005082357A8 Use of beta-lapachone for treating hematologic tumors |
| 04/20/2006 | WO2005033098A8 Salts and polymorphs of a pyrrole-substituted indolinone compound |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | WO2005023255A3 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
| 04/20/2006 | WO2004044164A3 Method for identifying risk of melanoma and treatments thereof |
| 04/20/2006 | US20060084819 Total synthesis of myriaporones |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/20/2006 | US20060084698 Methods for preparation and use of psorospermin analogs |
| 04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084661 IL-8 receptor antagonists |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | US20060084626 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 04/20/2006 | US20060084621 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 04/20/2006 | US20060084614 Anticoagulants; bioavailability, lower toxicity; 1-(glycosyl substituted phenylmethylamino)-4-amidino-benzene derivatives |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | US20060084612 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 04/20/2006 | US20060084610 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 04/20/2006 | US20060084600 Human homologues of fused gene |
| 04/20/2006 | US20060084595 Complex comprising OCIF and polysaccharide |
| 04/20/2006 | US20060084148 April-a novel protein with growth effects |
| 04/20/2006 | US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants |
| 04/20/2006 | US20060084141 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
| 04/20/2006 | US20060084135 Compositions for manipulating the lifespan and stress response of cells and organisms |
| 04/20/2006 | US20060084118 Lymphocytes; transcription factors; interferons; diagnosis of autoimmune disease such as lupus |
| 04/20/2006 | US20060083792 Utilizing nanocrystalline silver metal, alloy or compound for localized tissue infections; reducing side effects; limiting overuse of antibiotics |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083778 Controlled release compositions of estradiol metabolites |
| 04/20/2006 | US20060083745 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/20/2006 | US20060083739 Treating prostate cancer with anti-ErbB2 antibodies |
| 04/20/2006 | US20060083711 Methods and products related to the intracellular delivery of polysaccharides |
| 04/20/2006 | US20060083684 Method of radio-labelling biomolecules |
| 04/20/2006 | DE3991505B4 Somatostatinpeptide, deren Analoga oder Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen Somatostatin peptides, their analogues or derivatives, to processes for their preparation and pharmaceutical compositions containing them |
| 04/20/2006 | DE202005015707U1 Kräuterzusammensetzung zur Behandlung von Krebs Herb composition for the treatment of cancer |
| 04/20/2006 | DE19830167B4 Neue Azatyrosin-Analoga New azatyrosine analogues |
| 04/20/2006 | DE102004050952A1 Use of a beta-3-adrenoreceptor-agonist for the prophylaxis and/or treatment of e.g. benign prostata hyperplasia and/or its associated symptoms and chronic pelvic base pain syndrome, pelvic myoneuropathy, prostatodynia or prostatopathy |
| 04/20/2006 | DE102004050910A1 Composition containing phospholipid, sterol and negative charge carrier, useful e.g. for treating parasitic diseases and tumors, acts by stimulating leucopoiesis |
| 04/20/2006 | DE102004050196A1 Substituierte 2-Pyridon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted 2-pyridone derivatives, processes for their preparation and their use as a medicament |
| 04/20/2006 | DE102004049910A1 Composition for photodynamic therapy or diagnosis, useful for treating cancer and skin disorders, comprises chlorin e6, purpurin 5 and poly(vinyl pyrrolidone) |
| 04/20/2006 | DE102004049622A1 Novel para-sulfonamido-substituted 2-anilinopyrimidines are useful in a wide range of medicaments and as cell cycle kinase inhibitors or receptor tyrosine kinase inhibitors |
| 04/20/2006 | CA2626049A1 Methods and therapeutic compositions comprising plant extracts for the treatment of cancer |
| 04/20/2006 | CA2597341A1 Depression of herg k+ channel function in mammalian cells and applications to the control of cancer cells division |
| 04/20/2006 | CA2584185A1 Heterocyclic substituted bisarylurea derivates as kinase inhibitors |
| 04/20/2006 | CA2584179A1 N,n'-diphenylurea derivatives which are suitable as kinase inhibitors |
| 04/20/2006 | CA2583499A1 Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof |
| 04/20/2006 | CA2583311A1 Quinazolinylmethylenethiazolinones as cdk1 inhibitors |
| 04/20/2006 | CA2583192A1 1,5-naphthyridine azolidinones having cdk1 antiproliferative activity |
| 04/20/2006 | CA2583096A1 Quinoxalines as b raf inhibitors |
| 04/20/2006 | CA2583092A1 Antiangiogenic calixarene-based peptide mimetics |
| 04/20/2006 | CA2582986A1 Novel azaindole thiazolinones as anti-cancer agents |
| 04/20/2006 | CA2582985A1 Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer |
| 04/20/2006 | CA2581516A1 Quinazoline derivatives |
| 04/20/2006 | CA2579288A1 Thiazolyldihydroindazoles |
| 04/20/2006 | CA2579279A1 Tricyclic thiazole derivatives as pi3 kinases |
| 04/20/2006 | CA2577598A1 Modulators of hepatocyte growth factor activator |
| 04/19/2006 | EP1647599A2 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |
| 04/19/2006 | EP1647277A1 Glycoside-containing liposome |
| 04/19/2006 | EP1647271A1 4-Hydroxy tamoxifen gel formulations |
| 04/19/2006 | EP1647256A1 Dendritic cell infiltrativity activating composition and immune activator |
| 04/19/2006 | EP1646869A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/19/2006 | EP1646656A2 Human antibody molecules for il-13 |
| 04/19/2006 | EP1646649A1 7a5/prognostin and use thereof for the diagnostic and therapy of tumors |
| 04/19/2006 | EP1646639A2 Nucleotide phosphoramidates as anticancer agents |